Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin delivery devices, and it has now firmed up the alliance. Lilly has taken a ...

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo as ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose ...

DexCom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a new personalised learning ...

Continuous glucose monitoring may have a role in identifying and preventing diabetes among healthy adults, but more studies ...

An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.

Mercey Livingston is a health and wellness writer and certified Integrative Nutrition Health Coach. She's written about fitness and wellness for Well+Good, Women's Health, Business Insider, and ...

Dexcom’s G6 (left) and G7 (right) side-by-side. [Image from Dexcom] A Dexcom (NSDQ:DXCM) communication on its website states that it will soon cease manufacturing for its G6 continuous glucose monitor ...

Stay safe with updates on recalls, or tackle issues yourself with how-tos from our experts. Search for recalls by car Find out if there are recalls on a car you own or are interested in. Learn about ...

DexCom has been in for a rough ride this year. The medical technology company is grappling with concerns over its slowing growth and allegations of faulty blood glucose monitors.

The Insulet Omnipod 5 pump and Dexcom G7 15 Day CGM. [Images courtesy of the companies] Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom ...